Biotech and Pharma Stocks

Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.

BIOTECH & PHARMA

Medlab Clinical heads into H2 2021 with strong momentum following ‘very pleasing’ H1

Medlab Clinical partners with Arrotex to accelerate NanoCBD availability in Australian pharmacies

Greenlab signs medicinal cannabis supply deal with Australia’s largest distributor Cannvalate

Invex Therapeutics appoints biotech expert Dr Megan Baldwin to its board

Incannex Healthcare’s drug candidate IHL-675A could become a multi-use medication

PharmAust calls for more dogs for anti-cancer canine drug trial

Medlab Clinical’s probiotic NRGBiotic found to assist in reducing depression symptoms

BARD1 Life Sciences’ licenced SubB2M technology has ‘exquisite specificity’ in detecting ovarian cancer

Incannex Healthcare attracts interest as Austrian clinic uses CBD to treat COVID-19

Avecho Biotechnology raises $5.06m to develop pharmaceutical cannabinoid products

Alterity Therapeutics receives funding from Michael J Fox Foundation for Parkinson’s disease clinical trials

Incannex Healthcare study finds lead drug IHL-675A has ‘superior’ anti-inflammatory capabilities

Osteopore reports consistent revenue growth and upscales global distribution

Incannex Healthcare achieves another quarter of record sales, therapeutic portfolio advances

PharmAust seeks more canine participants for phase IIb lymphoma trial using lead drug monepantel

PharmAust begins next trial using monepantel to treat canines with lymphoma

Medlab Clinical to confirm NanaBis’ potential as non-opioid pain treatment in phase three trials

Invex Therapeutics pushes on with phase three trial design to repurpose drug for brain disorder

Medlab Clinical collars US FDA IND approval for cancer-pain treatment NanaBis

FDA approval paves way for Acrux to launch generic testosterone topical solution in US

Dr David Stamler steps-up as chief executive officer to lead Alterity Therapeutics’ commercialisation plans